What Medicine Can Actually Do for Opioid Dependence

Understanding What Is Being Treated

Before evaluating treatment options, it helps to be precise about what opioid treatment is addressing. There are two related but distinct conditions:

Physical dependence is the body's biological adaptation to opioids. With consistent use, the brain down-regulates its own endorphin production and adjusts receptor sensitivity to accommodate the external supply. When the supply is removed, withdrawal occurs. Physical dependence is not a behavioral disorder. It is a physiological reality that can develop in anyone who takes opioids consistently, including patients who follow their prescription exactly as written.

Opioid use disorder (OUD) is a clinical diagnosis that includes compulsive use despite harmful consequences, loss of control, cravings, and dysfunction in social, occupational, or personal domains. OUD involves changes in brain circuits beyond simple receptor adaptation, including alterations in reward processing, motivation, and impulse control. The National Institute on Drug Abuse (NIDA) maintains a detailed overview of evidence-based approaches for each stage of care.

Every patient who presents for opioid treatment has physical dependence. Not every patient has opioid use disorder. The treatment plan should reflect which condition, or combination of conditions, is present. A person who is physically dependent but does not meet criteria for OUD may need a different approach than someone with a severe, longstanding use disorder. For a deeper discussion of how this distinction shapes treatment choices, see the homepage overview.

Inpatient Hospital-Based Medical Detox

Hospital-based medical detoxification is the process of clearing opioids from the body under continuous physician supervision in an inpatient medical setting. It is the most medically intensive form of detox available and is considered the safest environment for managing opioid withdrawal, particularly for patients with complex medical histories. For comprehensive guidance on detox options, timelines, and costs, see GetDetox.com.

For broader context on why treatment access matters, GetDetox tracks the latest overdose statistics from CDC and SAMHSA.

The Protocol

Upon admission, the patient undergoes a comprehensive medical evaluation including blood work, cardiac monitoring, and assessment of withdrawal severity using standardized scales such as the Clinical Opiate Withdrawal Scale (COWS). A physician develops an individualized detox protocol based on the substance used, the duration and severity of dependence, and any co-occurring medical conditions. The Substance Abuse and Mental Health Services Administration (SAMHSA) publishes clinical guidelines for detox and medication-assisted treatment that inform most hospital protocols.

Medications commonly used during hospital detox include:

• Clonidine - an alpha-2 agonist that reduces autonomic withdrawal symptoms such as sweating, elevated heart rate, and agitation
• Benzodiazepines - used cautiously for severe anxiety, insomnia, and muscle spasms
• Anti-emetics - for nausea and vomiting
• Non-opioid analgesics - for muscle and bone pain
• Short opioid tapers - in some protocols, a controlled taper using a short-acting opioid or buprenorphine may be used to ease the transition

Vital signs are monitored continuously or at frequent intervals. Nursing staff provides 24-hour care. The acute withdrawal phase typically lasts five to ten days, depending on the substance. Fentanyl withdrawal may take longer due to the drug's accumulation in fatty tissue.

Who It Is For

Hospital-based detox is appropriate for patients who want to stop opioids entirely and need medical oversight during withdrawal. It is particularly recommended for patients with co-occurring medical conditions such as cardiovascular disease, diabetes, or respiratory conditions, patients with a history of complicated withdrawal, patients who have been unable to complete withdrawal in less supervised settings, and patients who are medically fragile or elderly.

What It Does and Does Not Do

Hospital detox resolves physical dependence. It clears the drug from the body and manages withdrawal safely. It does not, by itself, treat opioid use disorder. Detox is the beginning of treatment, not the treatment itself. Patients who complete hospital detox should have a structured post-detox plan in place, which may include naltrexone therapy, outpatient counseling, or residential rehabilitation. Relapse rates after detox alone are high, and the risk of overdose is elevated in the period immediately following detox because tolerance has been reduced. For more on how hospital detox fits into the broader continuum of care, see our inpatient vs outpatient guide.

Rapid Detox Under Sedation

Rapid or ultrarapid detoxification uses opioid antagonists while a patient is sedated or under anesthesia to trigger withdrawal over a short period. CDC and ASAM guidance advises against anesthesia-assisted ultrarapid opioid detoxification because it carries substantial risks, including serious adverse events and death, without evidence of better long-term outcomes.

Hospital accreditation, screening, and monitoring do not remove those guideline concerns. Patients should be offered evidence-based OUD treatment, overdose-prevention planning, and a clear path to continuing care rather than a detox-only procedure.

Naltrexone and Vivitrol

Naltrexone is an opioid antagonist. It binds to opioid receptors and blocks them without activating them. It produces no high, no sedation, no euphoria, and no physical dependence. It is fundamentally different from methadone and buprenorphine in both mechanism and clinical profile.

How It Works

Once naltrexone occupies opioid receptors, any opioid the person takes will be unable to produce its usual effect. The receptors are blocked. This removes the pharmacological incentive for relapse. If a person on naltrexone uses heroin or fentanyl, they will not feel the high. Over time, this decouples the association between opioid use and reward, which is one of the core drivers of addiction.

Naltrexone is available in two forms:

• Oral naltrexone - a daily pill, typically 50mg, taken each morning. Requires daily compliance.
• Vivitrol - an extended-release injectable form administered once per month by intramuscular injection. Eliminates the issue of daily compliance and provides consistent receptor blockade for approximately 30 days.

Requirements

Naltrexone cannot be started while opioids are still present in the body. Doing so will cause precipitated withdrawal, a sudden and severe withdrawal syndrome caused by the abrupt displacement of opioids from receptors. The patient must be fully detoxed before naltrexone can be initiated. For short-acting opioids, this typically means seven to ten days of abstinence. For long-acting opioids like methadone, ten to fourteen days may be required. For fentanyl, the waiting period may be longer. A naloxone challenge test can confirm that receptors are clear before the first dose.

Who It Is For

Naltrexone is best suited for patients who have completed detox and want to maintain abstinence without taking an opioid-based medication. It is a strong option for patients who are motivated, have a supportive environment, and want to achieve full opioid independence. The injectable form, Vivitrol, is particularly useful for patients who may struggle with daily medication adherence. Naltrexone is not appropriate for patients who are still actively using opioids or who have not completed detoxification.

Medications for Opioid Use Disorder: Methadone and Buprenorphine

Methadone and buprenorphine are FDA-approved medications for opioid use disorder. Both reduce illicit opioid use, overdose risk, and mortality. Counseling should be offered, but lack of counseling should not prevent access to buprenorphine.

Methadone

Methadone is a full opioid agonist, meaning it fully activates opioid receptors. It is dispensed through federally regulated opioid treatment programs (OTPs) and, in most cases, requires daily visits to a clinic for supervised dosing, at least in the early phases of treatment. Methadone has the longest track record of any medication for opioid dependence, with research dating to the 1960s. It is effective at suppressing withdrawal, reducing cravings, and reducing illicit opioid use. It is also associated with reduced rates of HIV transmission, criminal activity, and overdose death.

The limitations of methadone include the daily clinic visits required for most patients, the potential for diversion, and the fact that methadone itself can cause overdose if taken in excessive doses or combined with other central nervous system depressants. Methadone withdrawal, when a patient decides to taper off, can be prolonged and difficult, sometimes lasting weeks to months.

Buprenorphine (Suboxone, Subutex, Sublocade)

Buprenorphine is a partial opioid agonist. It activates opioid receptors but with a ceiling effect, meaning that beyond a certain dose, additional buprenorphine does not produce increased opioid effects. This ceiling reduces the risk of overdose compared to full agonists. Buprenorphine can be prescribed in office-based settings, making it more accessible than methadone for many patients.

Suboxone combines buprenorphine with naloxone, an antagonist that is included to deter misuse by injection. Sublocade is a monthly injectable form that provides sustained release. Buprenorphine is effective at preventing withdrawal and reducing cravings. It has a lower abuse potential than methadone but does carry a risk of diversion and misuse, particularly in its earlier formulations.

Treatment Duration and Physical Dependence

Physical dependence can occur during appropriate treatment, but it is distinct from addiction. There is no fixed time limit for methadone or buprenorphine treatment, and neither medication should be described as merely substituting one addiction for another.

Patients who want to stop should use a gradual, voluntary plan developed with their prescriber. Overdose-prevention planning and naloxone access are important because risk can increase after treatment ends.

Behavioral Therapy and Psychiatric Care

Medications address the neurochemistry of opioid dependence. Behavioral therapy addresses the psychology. The two are complementary, and the most effective treatment plans typically include both.

Cognitive Behavioral Therapy (CBT)

CBT helps patients identify thought patterns and situations that trigger opioid use, and develop practical strategies to manage them. It is structured, time-limited, and has a strong evidence base for substance use disorders. CBT teaches skills that remain useful long after therapy ends.

Motivational Interviewing (MI)

MI is a collaborative, goal-oriented counseling style designed to strengthen a person's own motivation for change. It is particularly useful in the early stages of treatment when ambivalence about recovery is common. MI does not confront or pressure. It helps the patient articulate their own reasons for seeking change.

Trauma-Informed Care

Many people with opioid dependence have histories of trauma, including childhood abuse, neglect, violence, or other adverse experiences. Trauma-informed care recognizes this and integrates trauma treatment into the recovery process rather than treating substance use in isolation. Approaches like EMDR (Eye Movement Desensitization and Reprocessing) and trauma-focused CBT can be incorporated into the treatment plan.

Psychiatric Evaluation and Co-Occurring Disorders

Depression, anxiety, PTSD, bipolar disorder, and other psychiatric conditions frequently co-occur with opioid dependence. A psychiatric evaluation should be part of any comprehensive treatment plan. Untreated mental health conditions are among the strongest predictors of relapse. Medications for co-occurring disorders, such as antidepressants or mood stabilizers, may be an important component of the overall treatment plan.

Peer Support

Recovery coaches, mutual aid groups, sober living communities, and peer-run recovery centers provide practical and emotional support that complements clinical treatment. Peer support is not a substitute for medical care, but it plays a valuable role in sustaining motivation, building community, and navigating the daily challenges of early recovery. For more on how therapy and counseling fit into the treatment process, see what to expect in treatment.

The Principle of Individualized Care

No single treatment works for everyone. The substance matters. The duration and severity of use matter. Co-occurring psychiatric and medical conditions matter. The patient's living situation, support system, employment, and personal goals all matter. A 25-year-old who has been using fentanyl for six months is in a different clinical situation than a 60-year-old who has been on prescription opioids for a decade.

The ASAM Criteria, developed by the American Society of Addiction Medicine, provides a standardized framework for matching patients to the appropriate level and type of care. It evaluates six dimensions: withdrawal potential, biomedical conditions, emotional and behavioral conditions, readiness to change, relapse potential, and recovery environment.

Treatment should never be prescribed by default. The question should always be: what does this specific patient need, at this specific point in time, given their specific circumstances? That is the standard every treatment provider should be held to, and it is the standard every patient and family has the right to expect.

What is the difference between opioid detox and opioid treatment?

Detoxification is the process of clearing opioids from the body while managing withdrawal symptoms. It addresses physical dependence, which is the body's biological adaptation to the presence of opioids. Treatment is the broader clinical effort to address the full scope of opioid use disorder, including the behavioral, psychological, and social dimensions. Detox resolves the immediate physical crisis. Treatment addresses the underlying condition. Detox alone has high relapse rates because it does not change the neurological patterns, environmental triggers, or psychological factors that drive continued use. The most effective approach is detox followed by a structured treatment plan that may include naltrexone, behavioral therapy, psychiatric care, or maintenance medication.

How does hospital-based medical detox differ from going to a rehab facility?

Hospital-based medical detox takes place in a hospital or accredited medical facility with physician oversight, nursing staff, and the ability to manage medical emergencies. It is focused on the acute withdrawal phase, typically lasting five to ten days. A rehab facility, or residential treatment center, provides a longer-term therapeutic environment, usually 30 to 90 days, that includes counseling, group therapy, life skills training, and aftercare planning. Rehab addresses the behavioral and psychological dimensions of opioid use disorder. Many patients complete hospital detox first and then transition to residential rehabilitation. Some residential programs include on-site medical detox, but the medical resources available in a hospital setting are generally more comprehensive, particularly for patients with co-occurring medical conditions.

What is precipitated withdrawal and why does it matter?

Precipitated withdrawal can occur when an opioid antagonist or, in some circumstances, buprenorphine is introduced before a patient is ready. Clinicians reduce this risk by choosing an induction protocol based on the opioid used, timing, symptoms, and the patient's clinical condition. Patients should not attempt induction without medical guidance.

Can a person on Suboxone still become addicted to opioids?

Buprenorphine, the active opioid in Suboxone, is a partial agonist. It activates opioid receptors but to a lesser degree than full agonists like heroin or fentanyl. While buprenorphine reduces cravings and prevents withdrawal, a person taking it is still physically dependent on an opioid. If buprenorphine is stopped abruptly, withdrawal will occur. Whether a person on Suboxone can develop addictive patterns depends on how the medication is used. When taken as prescribed under medical supervision, buprenorphine is generally stable and does not produce the euphoric highs associated with misuse. However, buprenorphine can be misused, particularly in its non-film formulations, and diversion does occur. The key distinction is that Suboxone manages dependence, it does not eliminate it. Patients should understand this when making long-term treatment decisions.

How long after stopping opioids can naltrexone be started?

Naltrexone requires an opioid-free period because starting it too soon can cause precipitated withdrawal. The required interval varies by opioid, dose, duration, and individual factors, so a qualified clinician should determine readiness and may use a naloxone challenge when appropriate.

Is there a treatment approach that uses no opioids at all?

Yes. A treatment pathway that uses no opioids would typically involve medically supervised detoxification to clear the opioid from the body, followed by naltrexone (an opioid antagonist that is not itself an opioid) to prevent relapse, combined with behavioral therapy and psychiatric support. This approach achieves full opioid independence, meaning the patient is not taking any opioid-based medication on an ongoing basis. It is best suited for patients who have completed detox successfully, are medically stable, have a supportive living environment, and are motivated to maintain abstinence. Not every patient is a candidate for this pathway, but for those who are, it offers a treatment model that does not involve ongoing opioid dependence of any kind.

Does rapid detox under anesthesia produce better long-term outcomes?

Evidence does not show better long-term outcomes, and CDC and ASAM advise against anesthesia-assisted ultrarapid detoxification because of serious safety risks. Evidence-based OUD medications and continuing care should be prioritized.